Latest Headlines

  1. Cambrex Unveils $120 Million Investment To Expand API Manufacturing And Strengthen U.S. Drug Supply Resilience 10/22/2025

    Cambrex, a leading global CDMO, is addressing increased demand for API development and manufacturing and accelerating the company’s leadership role in the fast-growing peptide therapeutics market.

  2. Merck Announces Plans For $3 Billion Small Molecule Drug Manufacturing Expansion In Virginia 10/22/2025

    Governor Glenn Youngkin announced today that Merck, known as MSD outside of the United States and Canada, is starting construction on a $3 billion, 400,000-square-foot pharmaceutical manufacturing facility that will serve as Merck’s Center of Excellence for Pharmaceutical Ingredients and Small Molecule Manufacturing, and generate 500 jobs at its Elkton, Virginia, site. Merck’s announcement reflects a significant increase beyond the original scope of a $2 billion investment and 300 jobs. The expansion is part of Merck’s $70 billion commitment to domestic research, development, and capital projects. 

  3. Comecer To Exhibit Aseptic Filling Solutions At ISPE Annual Meeting 2025 10/17/2025

    Comecer will be exhibiting at the ISPE Annual Meeting & Expo 2025, on October 26 - 29 at the Charlotte Convention Center in North Carolina, USA.

  4. 3P Innovation's Fill2Weight Technology Expands High-Precision Filling Capability At The CDMO, Upperton 10/16/2025
  5. Ensera Launches As New Brand Identity For SteriPack 10/14/2025

    New trading name reflects expanded expertise across design, manufacturing, assembly and packing for global pharma and medical device companies.

  6. Jubilant HollisterStier LLC Launches New High-Speed Isolator Based Line, At Its Spokane Manufacturing Facility In The US 10/14/2025

    Jubilant Pharmova Limited announced today that Jubilant HollisterStier LLC (JHS)—a wholly owned subsidiary and a leading North American pharmaceutical contract manufacturer, specialising in sterile injectables and serving top global innovator pharma companies—successfully launched its New Sterile Fill & Finish line, third at its Spokane Manufacturing Facility in Washington, US. The launch was marked by the successful production of the inaugural batch, initiating revenue generation from the new Line. This milestone denotes a significant advancement in Jubilant HollisterStier's multi-phase expansion strategy and brings an additional 50% capacity at its Spokane manufacturing facility.

  7. Quotient Sciences And Biorasi Partner To Accelerate Early Phase Clinical Trials To Patient Proof-Of-Concept 10/14/2025

    Quotient Sciences, a leading global drug development, research and manufacturing accelerator, and Biorasi, a global clinical research organization (CRO), today announced a strategic partnership to deliver fully integrated early phase clinical trial solutions.

  8. Ypsomed Investing $195M Into Holly Springs, NC Drug Manufacturing Facility 10/10/2025

    Ypsomed announced plans Oct. 9 to invest $195.4M in Holly Springs for its first North American manufacturing facility. The company will purchase and customize an existing 110,000-square-foot building in the YIELD Holly Springs. This purpose-built manufacturing campus is part of the broader Holly Springs Business Park, located just off N.C. 55. Ypsomed has committed to creating 62 high-quality jobs.

  9. Lupin To Build New Drug Manufacturing Facility In Coral Springs, Florida 10/10/2025

    Global pharmaceutical leader, Lupin, today announced its plans for a new state-of-the-art pharmaceutical manufacturing plant in Coral Springs, a significant step in safeguarding the health and safety of Florida families and the nation.

  10. Groninger Invests In The Future: Building A state-Of-The-Art Assembly Hall At Its Crailsheim Headquarters 10/8/2025

    groninger is expanding: A new assembly hall and adjoining office complex are being built, covering more than 75,000 square feet. With an investment volume of over 30 million euros, it marks the largest single investment in the company’s history.